Winner

Healthcare - Emerging Corporates

Award Function

  • B0367_2015_0 B0367_2015_0
CMPOne Day(%)Weekly(%)Monthly(%)Quarterly(%)Half Yearly(%)Year(%)YTD(%)52 Weeks High52 Weeks Low
628.45 -42.59 -42.59 -42.59 -42.59 -42.59 -42.59 -42.59
* Not adjusted for Corporate Action i.e. Bonus / Split / Dividend
Report DateResearch houseDescriptionRecoAt PriceTarget PriceUpSide
/DownSide
Download
11-Apr-18 SPA Securities Front runner in Biosimilars to guide revenues going ahead 612
3-Dec-17 Motilal Oswal Mylan/ Biocon received Trastuzumab approval in US Neutral 447 485 8.5
27-Oct-17 Nirmal Bang Sec Slowdown In Biosimilar Business As Well As Licensing Income Sell 360 308 -14.44
2-May-17 Nirmal Bang Sec Lower Licensing Income And Decline In Syngene Revenues Hurt Earni.. Sell 1104 739 -33.06
2-May-17 Isec Subdued Q4; biosimilars progress to hold key Hold 1100 1020 -7.27


Analyst Calls / Meets


Management Interviews

27-Apr-18 Kiran Mazumdar ..  
20-Jan-18 Kiran Mazumdar ..  
20-Nov-17 Kiran Mazumdar ..  
27-Oct-17 Kiran Mazumdar ..  
12-Jun-17 Kiran Muzumdar ..  

Investor Presentations

31-May-18 Investor/Anal...
30-Jun-17 Investor/Anal...
28-Apr-17 Investor/Anal...
01-Feb-17 Investor/Anal...
30-Nov-16 Investor/Anal...

Annual Reports
Source: Reportjunction.com

2016-17  
2015-16  
2014-15  
2013-14  
2012-13  

Research Showcase

11-Apr-18
SPA Securities ..
Download
03-Dec-17
Motilal Oswal -..
Download
27-Oct-17
Nirmal Bang Sec..
Download
02-May-17
Nirmal Bang Sec..
Download
02-May-17
Isec - Quarter ..
Download

Results

27-Apr-18 Results
24-Jan-18 Results
27-Jul-17 Results
27-Apr-17 Results
24-Jan-17 Results

AGM/EGM/Board Meetings

08-Dec-17 - POM
26-Oct-17 - Quarterly Results
28-Jul-17 - AGM
27-Jul-17 - Quarterly Results
07-Jun-17 - POM

Company Announcements

09-May-18
5:52 PM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Company Update Annoucements
21-Sep-17
12:00 AM
Analyst / Investor Meet - Intimation Company Update Annoucements
18-Sep-17
12:00 AM
Press Release / Media Release Company Update Annoucements
15-Sep-17
12:00 AM
Analyst / Investor Meet - Intimation Company Update Annoucements
08-Sep-17
12:00 AM
Analyst / Investor Meet - Intimation Company Update Annoucements

RB Model Portfolio

24-May-18 VTandon bought 68586  Shares RB Model Portfolio
23-May-18 VTandon bought 87414  Shares RB Model Portfolio
25-Jan-18 Ashish100 bought 10000  Shares
25-Jan-18 MV71380 bought 20000  Shares RB Model Portfolio
19-Jan-18 MV71380 bought 20000  Shares RB Model Portfolio

Press Release

18-Jan-18 Press Release
18-Jan-18 Press Release
25-Oct-17 Press Release
10-Oct-17 Press Release
18-Sep-17 Press Release

 

Credit Ratings

12-Jan-17 Short-Term Rating ICRA A1+ Reaffirmed
12-Jan-17 Long-Term Rating [ICRA]AA+ (Stable) Reaffirmed
11-Aug-16 Short-Term Rating CRISIL A1+ Reaffirmed
11-Aug-16 Long-Term Rating CRISIL AA+/Stable Reaffirmed
08-Sep-15 Short-Term Rating ICRA A1+ Reaffirmed

Archived Documents

No Archieved Transcript.